The Impact of Sinopharm COVID-19 Vaccination on Male Fertility
NCT ID: NCT04946565
Last Updated: 2021-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2021-07-03
2022-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Covid-19 Vaccination on Male
NCT05299307
Trigger Protocol on the Rate of Pregnancy After Intracytoplasmic Sperm Injection
NCT06966219
Sperm DNA Damage to Intracytoplasmic Sperm Injection Outcome
NCT03129243
Semen Analysis Parameters Following Pfizer's COVID-19 Vaccine
NCT04778033
Semen Parameters and COVID-19 in Infertile Men
NCT04643522
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sinopharm vaccine group
Participants scheduled to receive the Sinopharm vaccine will be evaluated on its effect on semen parameters for up to 6 months post vaccination.
Semen analysis
Semen analysis according to WHO laboratory manual for the examination and processing of human semen, Fifth edition
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Semen analysis
Semen analysis according to WHO laboratory manual for the examination and processing of human semen, Fifth edition
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Men who have been receiving Testosterone replacement therapy or anabolic steroids within the last year
* Men with a history of male infertility
* Men with a genetic or other medical condition known to be associated with decreased semen parameters Positive COVID-19 PCR test within the 3 months
18 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Tarek Anis
Professor of Andrology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohamed Tarek H Anis, M.D.
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine, Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TBA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.